In response to recent concerns about the use of mefloquine in the ADF Defence is releasing as much information as possible to assist current and ex-serving members and their families.
As such, Defence has decided to publish the full interview recently conducted by the ABC’s 730 with the Surgeon General of the ADF discussing the work done by Defence on this issue and the support that is available to those who are affected. The interview can be viewed at http://video.defence.gov.au/play/ZnMWYwNDE6aOl3JcjyiCqNRcXqanM2xC
More information on the use of anti-malarial drugs in the ADF is available at www.defence.gov.au/Health/HealthPortal/Malaria/or by contacting ADF.Malaria [at] defence.gov.au
If any ADF member, past or present, is concerned that they might be suffering from mefloquine side-effects it is important that they raise their concerns with a medical practitioner so they may receive proper treatment.
Issued by Ministerial and Executive Coordination and Communication,
Department of Defence,
Canberra, ACT
Phone: 02 6127 1999 Fax: 02 6265 6946
